FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Nuvalent's Trailing 12-Month Free Cash Flow is $-99.74 Mil, and Market Cap is $4,357.89 Mil. Therefore, Nuvalent's FCF Yield % for today is -2.29%.
The historical rank and industry rank for Nuvalent's FCF Yield % or its related term are showing as below:
NUVL'
s FCF Yield % Range Over the Past 10 Years
Min: -2.64 Med: 0 Max: 0
Current: -2.29
NUVL's FCF Yield % is ranked better than 78.71% of 1555
companies
in the Biotechnology industry
Industry Median: -14.18
vs NUVL: -2.29
The historical data trend for Nuvalent's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Nuvalent's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nuvalent's FCF Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nuvalent's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Nuvalent's FCF Yield % falls into.
Nuvalent FCF Yield % Calculation
FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Nuvalent's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nuvalent FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Nuvalent FCF Yield % Related Terms
Thank you for viewing the detailed overview of Nuvalent's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NUVL has been successfully added to your 